BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 221 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.69 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,466 | -28.6% | 207,095 | -29.0% | 0.07% | -22.5% |
| Q2 2023 | $2,053 | -5.7% | 291,556 | +11.7% | 0.09% | -13.6% |
| Q1 2023 | $2,177 | +20.1% | 260,986 | +65.2% | 0.10% | +3.0% |
| Q4 2022 | $1,813 | -99.9% | 157,944 | +62.6% | 0.10% | +35.1% |
| Q3 2022 | $1,224,000 | +48.4% | 97,127 | +24.5% | 0.07% | +19.4% |
| Q2 2022 | $825,000 | -25.5% | 77,988 | +14.5% | 0.06% | -15.1% |
| Q1 2022 | $1,108,000 | +298.6% | 68,114 | +239.6% | 0.07% | +108.6% |
| Q4 2021 | $278,000 | -3.5% | 20,056 | 0.0% | 0.04% | -7.9% |
| Q3 2021 | $288,000 | – | 20,056 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DG Capital Management, LLC | 1,186,726 | $4,076,000 | 2.45% |
| Sarissa Capital Management LP | 4,861,000 | $16,697,000 | 1.97% |
| Ghost Tree Capital, LLC | 1,950,000 | $6,698,000 | 1.94% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,525,857 | $8,676,000 | 1.14% |
| Eversept Partners, LP | 1,143,211 | $3,926,930 | 0.87% |
| DAFNA Capital Management LLC | 749,051 | $2,573,000 | 0.84% |
| KNOTT DAVID M | 397,361 | $1,365,000 | 0.80% |
| Parkman Healthcare Partners LLC | 800,740 | $2,751,000 | 0.73% |
| ACUTA CAPITAL PARTNERS, LLC | 660,000 | $2,267,000 | 0.62% |
| Formidable Asset Management, LLC | 578,200 | $1,949,000 | 0.57% |